Javelin Biotech
PrivateLast Round
Grant
Jun 16, 2026
Total Funding Raised
$4.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Javelin Biotech operates in Healthcare & Life Sciences and is based in Woburn, Massachusetts. Its latest recorded funding round was a Grant round in June 2026.
Javelin Biotech is a biotechnology company that develops predictive drug discovery platforms merging human tissue chips with computational biology and machine learning to improve preclinical R&D productivity.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Javelin Biotech Comparables
Compare Javelin Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xellar Biosystems | 85% | |
| BiomimX | 82% | |
| Vivodyne | 82% |
For institutional investors. Book with your work email.
Javelin Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 16, 2026 | ||||
| Grant | Aug 30, 2023 | ||||
| Grant | Aug 18, 2022 | ||||
| Grant | Sep 21, 2021 | ||||
| Seed | Sep 3, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Javelin Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shah Capital Partners | Seed |
| NIH RADx | Grant |
| Joyance Partners | Seed |
| InnoSpark Ventures | Seed |
| Social Starts | Seed |
| National Center for Advancing Translational Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 49% MoM, from 757 to 1.1K.
- May 15, 2026
Monthly visitors grew 208% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
Javelin Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Javelin Biotech's valuation, stock price, and market status.
Is Javelin Biotech a public or private company?
Javelin Biotech is a private company.
What is the current stock price of Javelin Biotech?
Javelin Biotech is a private company, so its shares have no public market price. Caplight tracks Javelin Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Javelin Biotech worth (valuation)?
Valuation information for Javelin Biotech is not publicly available.
Can I buy Javelin Biotech stock?
Javelin Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Javelin Biotech's last funding round?
Javelin Biotech's most recent funding round was Grant on June 16, 2026.
Who are the main investors in Javelin Biotech?
Key investors in Javelin Biotech include InnoSpark Ventures.
Will Javelin Biotech IPO soon?
No public IPO plans have been announced for Javelin Biotech.
How can I track Javelin Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Javelin Biotech's shares on secondary markets.